Electroretinographic (ERG) responses in pediatric patients using vigabatrin

Documenta Ophthalmologica

Volumn 124, Issue 3, 2012, Pages 197-209

  Moskowitz, Anne ^a   Hansen, Ronald M ^a   Eklund, Susan E ^a   Fulton, Anne B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Electroretinogram; Pediatric patients; Photoreceptor; Post receptor; Vigabatrin; Visual field

Indexed keywords

VIGABATRIN; ANTICONVULSIVE AGENT;

ARTICLE; B WAVE; CHILD; CHILD HEALTH CARE; CLINICAL EVALUATION; CONTROLLED STUDY; D WAVE; DARK ADAPTATION; ELECTRORETINOGRAPHY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PERIMETRY; PHOTOPIC VISION; PHOTORECEPTOR; PRIORITY JOURNAL; STIMULUS RESPONSE; TREATMENT DURATION; VISUAL FIELD DEFECT; VISUAL SYSTEM PARAMETERS; ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; INFANT; MIDDLE AGED; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; RETINA CONE; RETINA DISEASE; RETINA ROD; VISUAL ACUITY; VISUAL FIELD;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTRORETINOGRAPHY; HUMANS; INFANT; MIDDLE AGED; NERVOUS SYSTEM DISEASES; RETINAL CONE PHOTORECEPTOR CELLS; RETINAL DISEASES; RETINAL ROD PHOTORECEPTOR CELLS; VIGABATRIN; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 84865100702     PISSN: 00124486     EISSN: 15732622     Source Type: Journal    
DOI: 10.1007/s10633-012-9320-7     Document Type: Article

References (63)

1. Sabril (vigabatrin) Advisory Committee Briefing Document (2009) Ovation Pharmaceuticals. http://www.fda.gov/downloads/AdvisoryCommittees/ CommitteesMeetingMaterials/Drugs/ PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM153780.pdf
2. Kramer G, Wohlrab G (2008) Vigabatrin. In: Pellock JM, Bourgeois BFD, Dodson WE (eds) Pediatric epilepsy: diagnosis and therapy. Demos Medical Publishing, New York, pp 699-709
3. Royal College of Ophthalmologists (2008) The ocular sideeffects of vigabatrin (Sabril). Information and Guidance for Screening, London
4. Sergott RC, Wheless JW, Smith MC, Westall CA, Kardon RH, Arnold A, Foroozan R, Sagar SM (2010) Evidencebased review of recommendations for visual function testing in patients treated with vigabatrin. Neuro-ophthalmology 34:20-35
5. Eke T, Talbot JF, Lawden MC (1997) Severe persistent visual field constriction associated with vigabatrin. BMJ 314:180-181
6. Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR (2000) Visual function loss from vigabatrin: effect of stopping the drug. Neurology 55:40-45
7. Graniewski-Wijnands HS, van der Torren K (2002) Electroophthalmological recovery after withdrawal from vigabatrin. Doc Ophthalmol 104:189-194
8. Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG (2010) Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia 51: 2423-2431
9. Wild JM, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, Goldberg I, Goni FJ, Mercier F, Nordmann JP, Safran AB, Schiefer U, Perucca E (2009) Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study. CNS Drugs 23:965-982
10. Clayton LM, Devile M, Punte T, Kallis C, de Haan GJ, Sander JW, Acheson J, Sisodiya SM (2011) Retinal nerve fiber layer thickness in vigabatrin-exposed patients. Ann Neurol 69:845-854
11. Durbin S, Mirabella G, Buncic JR, Westall CA (2009) Reduced grating acuity associated with retinal toxicity in children with infantile spasms on vigabatrin therapy. Invest Ophthalmol Vis Sci 50:4011-4016
12. Miller NR, Johnson MA, Paul SR, Girkin CA, Perry JD, Endres M, Krauss GL (1999) Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings. Neurology 53:2082-2087
13. Paul SR, Krauss GL, Miller NR, Medura MT, Miller TA, Johnson MA (2001) Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making. Epilepsia 42:525-530
14. Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D (1999) Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 106:1792-1798
15. Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C (2000) Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology 55:347-352
16. Spencer EL, Harding GF (2003) Examining visual field defects in the paediatric population exposed to vigabatrin. Doc Ophthalmol 107:281-287
17. Besch D, Kurtenbach A, Apfelstedt-Sylla E, Sadowski B, Dennig D, Asenbauer C, Zrenner E, Schiefer U (2002) Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol 104:151-170
18. Coupland SG, Zackon DH, Leonard BC, Ross TM (2001) Vigabatrin effect on inner retinal function. Ophthalmology 108:1493-1496; discussion 1497-8
19. Comaish IF, Gorman C, Brimlow GM, Barber C, Orr GM, Galloway NR (2002) The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms. Doc Ophthalmol 104:195-212
20. Jensen H, Sjo O, Uldall P, Gram L (2002) Vigabatrin and retinal changes. Doc Ophthalmol 104:171-180
21. McCoy B, Wright T, Weiss S, Go C, Westall CA (2011) Electroretinogram changes in a pediatric population with epilepsy: is vigabatrin acting alone? J Child Neurol 26: 729-733
22. van der Torren K, Graniewski-Wijnands HS, Polak BC (2002) Visual field and electrophysiological abnormalities due to vigabatrin. Doc Ophthalmol 104:181-188
23. Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M (2002) The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Doc Ophthalmol 104:133-149
24. Morong S, Westall CA, Nobile R, Buncic JR, Logan WJ, Panton CM, Abdolell M (2003) Longitudinal changes in photopic OPs occurring with vigabatrin treatment. Doc Ophthalmol 107:289-297
25. Westall CA, Nobile R, Morong S, Buncic JR, Logan WJ, Panton CM (2003) Changes in the electroretinogram resulting from discontinuation of vigabatrin in children. Doc Ophthalmol 107:299-309
26. Mayer DL, Hansen RM, Moore BD, Kim S, Fulton AB (2001) Cycloplegic refractions in healthy children aged 1 through 48 months. Arch Ophthalmol 119:1625-1628
27. Zadnik K, Manny RE, Yu JA, Mitchell GL, Cotter SA, Quiralte JC, Shipp M, Friedman NE, Kleinstein RN, Walker TW, Jones LA, Moeschberger ML, Mutti DO (2003) Ocular component data in schoolchildren as a function of age and gender. Optom Vis Sci 80:226-236
28. McDonald MA, Dobson V, Sebris SL, Baitch L, Varner D, Teller DY (1985) The acuity card procedure: a rapid test of infant acuity. Invest Ophthalmol Vis Sci 26:1158-1162
29. Salomao SR, Ventura DF (1995) Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards. Invest Ophthalmol Vis Sci 36:657-670
30. Agrawal S, Mayer DL, Hansen RM, Fulton AB (2009) Visual fields in children treated with vigabatrin. Optom Vis Sci 86:767-773
31. Mayer DL, Fulton AB (2004) Visual fields. In: Taylor D, Hoyt CS (eds) Pediatric Ophthalmology and Strabismus. Elsevier Saunders, New York, pp 78-86
32. Wali N, Leguire LE (1992) The photopic hill: a new phenomenon of the light adapted electroretinogram. Doc Ophthalmol 80:335-345
33. Elias ER, Hansen RM, Irons M, Quinn NB, Fulton AB (2003) Rod photoreceptor responses in children with Smith Lemli Opitz syndrome. Arch Ophthalmol 121: 1738-1743
34. Garry D, Hansen RM, Moskowitz A, Elias ER, Irons M, Fulton AB (2010) Cone ERG responses in patients with Smith Lemli Opitz Syndrome (SLOS). Doc Ophthalmol 121:85-91
35. Wongpichedchai S, Hansen RM, Koka B, Gudas VM, Fulton AB (1992) Effects of halothane on children's electroretinograms. Ophthalmology 99:1309-1312
36. Fulton AB, Hansen RM (2000) The development of scotopic sensitivity. Invest Ophthalmol Vis Sci 41:1588-1596
37. Hansen RM, Fulton AB (2005) Development of the cone ERG in infants. Invest Ophthalmol Vis Sci 46:3458-3462
38. Lamb TD, Pugh EN Jr (1992) A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol 449:719-758
39. Pugh EN Jr, Lamb TD (1993) Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta 1141:111-149
40. Hood DC, Birch DG (1994) Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci 35:2948-2961
41. Aleman TS, LaVail MM, Montemayor R, Ying G, Maguire MM, Laties AM, Jacobson SG, Cideciyan AV (2001) Augmented rod bipolar cell function in partial receptor loss: an ERG study in P23H rhodopsin transgenic and aging normal rats. Vis Res 41:2779-2797
42. Wurziger K, Lichtenberger T, Hanitzsch R (2001) Onbipolar cells and depolarising third-order neurons as the origin of the ERG-b-wave in the RCS rat. Vis Res 41:1091-1101
43. Peachey NS, Alexander KR, Fishman GA (1989) The luminance-response function of the dark-adapted human electroretinogram. Vis Res 29:263-270
44. Friedburg C, Allen CP, Mason PJ, Lamb TD (2004) Contribution of cone photoreceptors and post-receptoral mechanisms to the human photopic electroretinogram. J Physiol 556:819-834
45. Hood DC, Birch DG (1995) Phototransduction in human cones measured using the alpha-wave of the ERG. Vis Res 35:2801-2810
46. Sieving PA (1993) Photopic ON- and OFF-pathway abnormalities in retinal dystrophies. Trans Am Ophthalmol Soc 91:701-773
47. McCulloch DL, Hamilton R (2010) Essentials of photometry for clinical electrophysiology of vision. Doc Ophthalmol 121:77-84
48. Fulton AB, Hansen RM, Moskowitz A, Akula JD (2009) The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 28:452-482.
49. Corrigendum 2010;29:94
50. Whitmore GA (1986) Prediction limits for a univariate normal observation. Am Stat 40:141-143
51. Cooper LL, Hansen RM, Darras BT, Korson M, Dougherty FE, Shoffner JM, Fulton AB (2002) Rod photoreceptor function in children with mitochondrial disorders. Arch Ophthalmol 120:1055-1062
52. Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD (2009) Vigabatrin: 2008 update. Epilepsia 50: 163-173
53. Wild JM, Robson CR, Jones AL, Cunliffe IA, Smith PE (2006) Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer. Invest Ophthalmol Vis Sci 47: 917-924
54. Schechter PJ, Tranier Y, Jung MJ, Bohlen P (1977) Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45:319-328
55. Sills GJ, Butler E, Forrest G, Ratnaraj N, Patsalos PN, Brodie MJ (2003) Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44:886-892
56. Hood DC, Birch DG, Birch EE (1993) Use of models to improve hypothesis delineation: A study of infant electroretinography. In: Simons K (ed) Early visual development normal and abnormal. Oxford University Press, New York, pp 517-535
57. Garry DJ, Coulter HD, McIntee TJ, Wu JY, Sorenson RL (1987) Immunoreactive GABA transaminase within the pancreatic islet is localized in mitochondria of the B-cell. J Histochem Cytochem 35:831-836
58. Robson JG, Maeda H, Saszik SM, Frishman LJ (2004) In vivo studies of signaling in rod pathways of the mouse using the electroretinogram. Vis Res 44:3253-3268
59. Herrmann R, Heflin SJ, Hammond T, Lee B, Wang J, Gainetdinov RR, Caron MG, Eggers ED, Frishman LJ, McCall MA, Arshavsky VY (2011) Rod vision is controlled by dopamine-dependent sensitization of rod bipolar cells by GABA. Neuron 72:101-110
60. Ueno S, Kondo M, Niwa Y, Terasaki H, Miyake Y (2004) Luminance dependence of neural components that underlies the primate photopic electroretinogram. Invest Ophthalmol Vis Sci 45:1033-1040
61. Nie D, Di Nardo A, Han JM, Baharanyi H, Kramvis I, Huynh T, Dabora S, Codeluppi S, Pandolfi PP, Pasquale EB, Sahin M (2010) Tsc2-Rheb signaling regulates EphAmediated axon guidance. Nat Neurosci 13:163-172
62. Good WV (2011) Measuring field loss in children administered vigabatrin: a problem in search of a solution. J AAPOS 15:411-412
63. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118: 69-77